Allen Burris
Endocrinology, Diabetes & Metabolism · Powhatan, VANPI 1487646485
Payments from drug & device makers
$261,099in general payments, 2019–2025
Across 667 payments — averaging $391.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$166K
- Lilly USA, LLC$36K
- AstraZeneca$22K
- Merck$17K
- Clarus Therapeutics Inc.$8K
- AbbVie$5K
- plus $6K from 38 others
General payments by program year
19
20
21
22
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$261,099 in reported general payments places this provider in the 95th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.
See all endocrinology, diabetes & metabolism providers in Virginia →
Other endocrinology, diabetes & metabolism in Powhatan
- Domenica RubinoArlington$3M
- Suzanne Jan de BeurCharlottesville$1.5M
- Farhad ZangenehSterling$1.2M
- Ali IranmaneshSalem$1.1M
- Elias SirajNorfolk$884K
- James MulindaRoanoke$788K
- Jeffrey SicatGlen Allen$657K
- Dewey BaileyRoanoke$645K
- James la RocqueChesapeake$576K
- Samamtha HudsonMidlothian$372K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.